Medical Condition News

RSS

EUROCARE 5 study shows large variations in blood cancer patients' survival in Europe

Comparisons of cancer patients' survival and care in Europe up to 2007 show that although more patients are surviving for at least five years after diagnosis, there are large variations between countries, which are particularly significant in cancers of the blood.

26 Sep 2015

Patients with advanced kidney cancer benefit from cabozantinib treatment

Patients with advanced kidney cancer live for nearly twice as long without their disease progressing if they are treated with cabozantinib, a drug that inhibits the action of tyrosine kinases - enzymes that function as an "on" or "off" switch in many cellular processes, including cancer.

26 Sep 2015

NIH-supported study explores effects of substance use on adolescent brain development

The National Institutes of Health today awarded 13 grants to research institutions around the country as part of a landmark study about the effects of adolescent substance use on the developing brain.

26 Sep 2015

Dried plum diet may help reduce colon cancer risk

Researchers from Texas A&M University and the University of North Carolina have shown a diet containing dried plums can positively affect microbiota, also referred to as gut bacteria, throughout the colon, helping reduce the risk of colon cancer.

26 Sep 2015

Smokers who have COPD may face increased risk of getting small cell lung cancer

Smokers who have chronic obstructive pulmonary disorder (COPD) may face nearly twice the risk of getting small cell lung cancer (SCLC)--the deadliest form of lung cancer--than smokers who don't have COPD, according to a large worldwide study led by researchers at the Harvard T.H. Chan School of Public Health.

26 Sep 2015

Many countries have a long way to go to reduce suffering, deaths from non-communicable disease

A new method published in the Lancet of monitoring countries' performance in reducing the burden of NCD (non-communicable disease), shows that many countries have a long way to go to reduce suffering and deaths from NCD.

26 Sep 2015

Immune checkpoint inhibitor increases survival in patients with advanced renal cell carcinoma

For the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited.

26 Sep 2015

New Kaiser Permanente study finds small decline in obesity rates among young people in Southern California

A new study from Kaiser Permanente found a small but significant decline in the percentage of young people who are overweight and obese in Southern California. The decline was seen across all ages, races and ethnicities, but was less pronounced in girls, adolescents, Hispanic and black children, according to the results published today in The Journal of Pediatrics.

26 Sep 2015

Dr. Sidney Goldstein to receive Heart Failure Society of America's Lifetime Achievement Award

The Heart Failure Society of America will award the prestigious Lifetime Achievement Award for the tenth time in its history. The 2015 recipient is Sidney Goldstein, MD. Dr. Goldstein lives in Detroit, MI.

26 Sep 2015

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration approved the new drug application for Tresiba (insulin degludec injection), a once-daily, long-acting basal insulin. Tresiba is indicated for use alone, or in combination with oral antidiabetic medicines or bolus insulin, and is approved for glycemic control in adults with type 1 and type 2 diabetes. Tresiba provides a long duration of action beyond 42 hours.

From Novo Nordisk 26 Sep 2015

University of Oslo researchers examine treatment methods for tennis elbow

The two most common treatments for tennis elbow are physiotherapy and cortisone injections. It is unclear which of these gives the best result, and diagnosis can be problematic for general practitioners. Now researchers at the University of Oslo have taken a closer look at the treatment methods.

25 Sep 2015

AbbVie plans to advance ABT-494 to Phase 3 studies in rheumatoid arthritis

AbbVie, a global biopharmaceutical company, today announced that it will advance ABT-494, its internally developed investigational selective JAK1 inhibitor, to Phase 3 studies in rheumatoid arthritis. Following a thorough review of available data, AbbVie will not exercise its right to in-license the Galapagos JAK1 inhibitor, filgotinib.

25 Sep 2015

Scientists compile complete genetic information of people affected by PAH

The genetic architecture of a debilitating and potentially fatal vascular disease has for the first time been detailed in its entirety, providing clinicians with the comprehensive data needed to improve diagnosis and deliver more personalised patient care.

25 Sep 2015

AbbVie reports positive results from ABT-494 Phase 2 clinical trials in patients with rheumatoid arthritis

AbbVie, a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its investigational selective JAK1 inhibitor, ABT-494, in patients with inadequate response to either methotrexate or TNF inhibitors.

25 Sep 2015

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

"We are pleased to receive positive CHMP opinions for Kyprolis and BLINCYTO as this is an important step in providing new treatment options for patients in Europe with rare forms of cancer," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen.

25 Sep 2015

Researchers develop new blood test to diagnose coeliac disease

Diagnosis of coeliac disease requires a tissue sample from the small intestine, which can be extremely unpleasant. Researchers at the Faculty of Medicine have developed a blood test which provides a rapid, painless answer.

25 Sep 2015

New guideline on the use of prescription medications for treatment of opioid addiction

Medications play an important role in managing patients with opioid use disorders, but there are not enough physicians with the knowledge and ability to use these often-complex treatments.

25 Sep 2015

Kessler Foundation study may simplify cognitive assessment for MS in clinical settings

Kessler Foundation scientists found that the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) predicted performance of activities of daily living using Actual Reality (AR). The article, "Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and performance of everyday life tasks," was published in Multiple Sclerosis Journal.

25 Sep 2015

Researchers identify new biochemical pathway that could be a potential target for insulin control

In the final event leading to the development of Type 2 diabetes, the pancreas loses its ability to secrete insulin and clear glucose from the blood. Preventing this breakdown in insulin secretion is a key goal in the fight to reduce the burden of a disease that afflicts an estimated 29 million people in the United States.

25 Sep 2015

CUMC's Laboratory of Personalized Genomic Medicine granted approval for Columbia Combined Cancer Panel

The Laboratory of Personalized Genomic Medicine at Columbia University Medical Center has been granted full approval by the New York State Department of Health for the Columbia Combined Cancer Panel, (CCCP). This panel queries 467 cancer-related genes and was designed in collaboration with Columbia University Medical Center oncologists.

25 Sep 2015

Medical Condition News

EUROCARE 5 study shows large variations in blood cancer patients' survival in Europe

Patients with advanced kidney cancer benefit from cabozantinib treatment

NIH-supported study explores effects of substance use on adolescent brain development

Dried plum diet may help reduce colon cancer risk

Smokers who have COPD may face increased risk of getting small cell lung cancer

Many countries have a long way to go to reduce suffering, deaths from non-communicable disease

Immune checkpoint inhibitor increases survival in patients with advanced renal cell carcinoma

New Kaiser Permanente study finds small decline in obesity rates among young people in Southern California

Dr. Sidney Goldstein to receive Heart Failure Society of America's Lifetime Achievement Award

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

University of Oslo researchers examine treatment methods for tennis elbow

AbbVie plans to advance ABT-494 to Phase 3 studies in rheumatoid arthritis

Scientists compile complete genetic information of people affected by PAH

AbbVie reports positive results from ABT-494 Phase 2 clinical trials in patients with rheumatoid arthritis

Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)

Researchers develop new blood test to diagnose coeliac disease

New guideline on the use of prescription medications for treatment of opioid addiction

Kessler Foundation study may simplify cognitive assessment for MS in clinical settings

Researchers identify new biochemical pathway that could be a potential target for insulin control

CUMC's Laboratory of Personalized Genomic Medicine granted approval for Columbia Combined Cancer Panel

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News